scholarly article | Q13442814 |
P2093 | author name string | K M Prasanna Kumar | |
Sanjeev Phatak | |||
Ami Sanghvi | |||
Chaitanya Kotla | |||
Manoj Chawla | |||
Nadiminty G Sastry | |||
Sanjay Choudhari | |||
P2860 | cites work | Standards of Medical Care in Diabetes-2017: Summary of Revisions | Q88988726 |
Understanding and overcoming metformin gastrointestinal intolerance. | Q30240030 | ||
Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes | Q33713860 | ||
Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus | Q33763380 | ||
Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatry | Q33949355 | ||
Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations | Q34410837 | ||
Diagnosis and treatment of swallowing disorders (dysphagia) in acute-care stroke patients | Q34582959 | ||
Oesophageal transit of six commonly used tablets and capsules | Q34766250 | ||
Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study. | Q35675566 | ||
Blood Glucose Control and Medication Adherence Among Adult Type 2 Diabetic Nigerians Attending A Primary Care Clinic in Under-resourced Environment of Eastern Nigeria | Q36132343 | ||
Safety, tolerability, and efficacy of metformin extended-release oral antidiabetic therapy in patients with type 2 diabetes: an observational trial in Asia | Q36546955 | ||
Compliance to anti-diabetic drugs: observations from the diabetic clinic of a medical college in kolkata, India | Q36816657 | ||
Factors affecting therapeutic compliance: A review from the patient's perspective | Q36822915 | ||
Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations | Q37423776 | ||
The current state of diabetes mellitus in India | Q37575753 | ||
Advantages of extended-release metformin in patients with type 2 diabetes mellitus | Q37835611 | ||
Patients' evaluation of shape, size and colour of solid dosage forms | Q47198281 | ||
The effect of size and shape of tablets on their esophageal transit | Q47212455 | ||
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. | Q47773960 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metformin | Q19484 |
type 2 diabetes | Q3025883 | ||
Noncompliance | Q4047355 | ||
P304 | page(s) | 147-159 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | International Journal of General Medicine | Q6051402 |
P1476 | title | Adherence, satisfaction, and experience with metformin 500 mg prolonged release formulation in Indian patients with type 2 diabetes mellitus: a postmarketing observational study | |
P478 | volume | 12 |
Q89538082 | Role of AYUSH Therapies in Modern Medicine: A Qualitative Study to Explore the Awareness and Attitudes of Doctors Towards the Utilization of Alternate System of Medicine for Diabetes Mellitus | cites work | P2860 |
Search more.